| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/27/2005 | CN1646528A Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 07/27/2005 | CN1646501A Nanofilm and membrane compositions |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646116A Macrocyclic module compositions |
| 07/27/2005 | CN1212317C Novel ester or amide derivatives |
| 07/26/2005 | US6921839 Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem |
| 07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
| 07/26/2005 | US6921771 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione or pharmaceutically acceptable salts |
| 07/26/2005 | US6921768 Cytostatic cerium compounds |
| 07/26/2005 | US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/26/2005 | US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |
| 07/26/2005 | CA2324848C Method of making camptothecin and camptothecin analogs |
| 07/26/2005 | CA2253948C Carboline derivatives |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/26/2005 | CA2149007C Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 07/21/2005 | WO2005066183A1 Spirocyclic cyclohexane derivatives with affinity for the orl1-receptor |
| 07/21/2005 | WO2005066172A1 Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 07/21/2005 | WO2005066171A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
| 07/21/2005 | WO2005066170A1 Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| 07/21/2005 | WO2005066169A2 Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| 07/21/2005 | WO2005066132A1 Therapeutic agents i |
| 07/21/2005 | WO2005066126A1 Cb1 modulator compounds |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | WO2005065416A2 Process for the preparation of pyridopyrimidones |
| 07/21/2005 | WO2005065370A2 Soluble polymers as amine capture agents and methods |
| 07/21/2005 | WO2005065183A2 Mitotic kinesin inhibitors |
| 07/21/2005 | WO2005065050A2 Bicyclic compound |
| 07/21/2005 | WO2004055004A8 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159443 For example, N-[2,4-dichloro-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-N-methyl-2-[1-methyl-5-(3-methyl-4-nitro-benzoyl)-1H-pyrrol-2-yl]-acetamide; bradykinin receptor agonists; for treating disorders such as pain, inflammation, asthma and allergy |
| 07/21/2005 | US20050159442 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors and methods of using the same |
| 07/21/2005 | US20050159438 Spirocyclic heterocyclic derivatives and methods of their use |
| 07/21/2005 | US20050159436 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 07/21/2005 | US20050159423 Antibacterial compounds |
| 07/21/2005 | US20050159413 selective for matrix metalloprotease 13 (MMP-13) over other MMPs and also over reprolysins such as TNF-alpha converting enzyme (TACE) and aggrecanase; anticancer, antiinflammatory; 1-[6-(4-Fluoro-phenoxy)-pyridin-3-yl]-1,8,10-triaza-spiro[5.5]undecane-2,7,9,11-tetraone |
| 07/21/2005 | US20050159411 Bactericides for infrections in man |
| 07/21/2005 | US20050159391 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 07/21/2005 | US20050159388 Non-nucleotide compositions and method for inhibiting platelet aggregation |
| 07/21/2005 | DE10360154A1 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia |
| 07/21/2005 | CA2552101A1 Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 07/21/2005 | CA2551399A1 Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| 07/21/2005 | CA2550717A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
| 07/21/2005 | CA2549641A1 Mitotic kinesin inhibitors |
| 07/21/2005 | CA2549396A1 Cb1 modulator compounds |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/20/2005 | EP1555265A1 7-phenyl pyrazolopyridine compounds |
| 07/20/2005 | EP1554277A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 07/20/2005 | EP1554276A1 Non-nucleoside reverse transcriptase inhibitors |
| 07/20/2005 | EP1554272A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 07/20/2005 | EP1554259A1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1553949A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/20/2005 | EP1553947A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 07/20/2005 | EP1553923A1 Camptothecin-carboxylate formulations |
| 07/20/2005 | EP1553916A2 Nuclear hormone receptor compounds, products and methods employing same |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1056717B1 Arylphenyl-substituted cyclic keto-enols |
| 07/20/2005 | CN1643105A Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
| 07/20/2005 | CN1642956A Dipyridodiazepinones as reverse transcriptase inhibitors |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642954A Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 07/20/2005 | CN1642953A Process for preparing crystalline form I of cabergoline |
| 07/20/2005 | CN1642949A Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642922A Substituted indazoles with anti-cancer activity |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1640876A Spiro dihydroindole template compound and its preparing method |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211385C Bicyclic imidazo-5-yl-amine derivs. |
| 07/20/2005 | CN1211382C Quinazoline ditosylate salt compounds |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/19/2005 | US6919461 Anticancer agents; antiarthritic agents |
| 07/19/2005 | US6919451 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
| 07/19/2005 | US6919368 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
| 07/19/2005 | US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 07/19/2005 | US6919352 Viricide against herpes virus |
| 07/19/2005 | US6919351 Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors |
| 07/19/2005 | US6919349 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/19/2005 | US6919345 Sulfonate substituted pyrazol pyridine derivatives |
| 07/19/2005 | US6919331 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| 07/19/2005 | US6919329 Microorganisms; bactericides; human and veterinary medicine |
| 07/19/2005 | US6918958 Acid pigment dispersants and pigment preparations |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063768A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
| 07/14/2005 | WO2005063767A2 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 07/14/2005 | WO2005063754A1 Triazole derivatives as vasopressin antagonists |
| 07/14/2005 | WO2005063749A1 Crf receptor antagonists and methods relating thereto |